FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma
FDA oncologists discuss the approval of avelumab for the treatment of patients 12 years and older with metastatic Merkel cell carcinoma.
Media formats available
Completing the pre-test is required to access this content.
Pre-Survey
Completing the pre-survey is required to access this content.
